Securing cheaper medicines and improved patient outcomes through 8th Community Pharmacy Agreement

14 March 2024 - The Albanese Government and Pharmacy Guild of Australia have reached a Heads of Agreement for an ...

Read more →

Updated agenda for March 2024 PBAC meeting (12 March 2024)

12 March 2024 - There are five late changes to the agenda for this week's PBAC meeting. ...

Read more →

Pharmaceutical reform agreement review report

6 March 2024 - The Department of Health and Aged Care has conducted a review of Pharmaceutical Reform Agreements (PRAs), to ...

Read more →

Updated agenda for March 2024 PBAC meeting (6 March 2024)

6 March 2024 - The agenda for this March 2024 meeting has been updated. ...

Read more →

Cheaper medicines with twice as many medicines now available for a 60 day prescription

3 March 2024 - The Albanese Government is making medicines cheaper by doubling the number of medicines now available for ...

Read more →

Australians with chronic heart failure benefit from cheaper medicines on the PBS

3 March 2024 - Australians with chronic heart failure now have access to cheaper medicines under the PBS. ...

Read more →

Public Summary Documents – November 2023 PBAC meeting (round 1)

1 March 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2023 PBAC ...

Read more →

More rare conditions considered for newborn bloodspot screening and new treatment option for spinal muscular atrophy

29 February 2024 - On Rare Disease Day, the Albanese Government has announced two more rare genetic conditions have been ...

Read more →

Schedule of Pharmaceutical Benefits - 1 March 2024

1 March 2024 - The March 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Updates to the HTA review research and analysis papers collection: emerging health technologies

15 February 2024 - The draft paper 'Emerging Health Technologies' developed to support the deliberations of the HTA Review Reference ...

Read more →

Updates to the HTA Review: consultation 2 survey

6 February 2024 - Access to the HTA Review Consultation 2 online survey is now available on the Office of ...

Read more →

Cheaper medicines for advanced melanoma and multiple sclerosis

5 February 2024 - From 1 February 2024, Australians with advanced melanoma and relapsing-remitting multiple sclerosis will have access to ...

Read more →

Schedule of Pharmaceutical Benefits - 1 February 2024

1 February 2024 - The February 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

2024 PBS post-market review framework

31 January 2024 - The 2024 post-market review framework is now available. ...

Read more →

Updates to the HTA Review: options paper for Consultation 2 published

25 January 2024 - The Options paper for Consultation 2 is now available on the Office of Health Technology Assessment consultation ...

Read more →